Ovarian Stimulation in Obese and Non-obese Polycystic Ovary Syndrome Using a Low-dose Step-up Regimen with Two Different Starting Doses of Recombinant Follicle-stimulating Hormone


Yildizhan R. , ADALI E., Kolusari A. , KURDOGLU M., YILDIZHAN B., SAHIN H. G. , ...Daha Fazla

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, cilt.36, ss.1197-1204, 2008 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 36 Konu: 6
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1177/147323000803600605
  • Dergi Adı: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
  • Sayfa Sayıları: ss.1197-1204

Özet

Sixty-seven infertile women with polycystic ovary syndrome (PCOS) were divided into two groups, obese and non-obese, according to their body mass index. Waist-to-hip ratio, insulin resistance, total testosterone and dehydroepiandrosterone sulphate levels were significantly elevated in obese, compared with non-obese, patients. Both groups were treated with a low-dose step-up protocol of recombinant follicle-stimulating hormone (rFSH) with a starting dose of 50 IU/day and, every third day, a 25-IU increase in the dose until the appropriate dose was achieved for each individual, up to a maximum of 175 IU/day. In the obese group only, repeat therapy commenced in the second ovulatory cycle in women who had not become pregnant, however a starting dose of 75 IU/day was then used, with incremental and maximum dose as before. The results of the starting dose of 75 IU/day rFSH were compared with the results of a 50 IU/day rFSH starting dose in the obese group. A starting dose of 50 IU/day rFSH in a low-dose step-up regimen was found to be effective, safe and well-tolerated for inducing follicular development in non-obese infertile women with PCOS. However, for obese PCOS patients, a starting dose of 75 IU/day rFSH is recommended.